13F Pro Quality Score

40.8/100

Rank #1,917 of 2,879 stocks

View Technology peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Aug 14, 2026.

Revenue Growth

66.3/100

Profitability

30.2/100

Balance Sheet

39.0/100

Earnings Quality

2.2/100

Free Cash Flow

48.3/100

Institutional Flow

18.4/100

Revenue Scale

23.7/100

Dilution Risk

75.6/100

ULBI Stock Analysis & AI Quality Score

AI stock analysis and institutional research for ULTRALIFE CORP (ULBI), a Technology sector company. 13F Pro's AI-powered ranking engine scores ULBI at 40.8/100 on a 32-signal composite quality model, placing it at rank #1,917 of 2,879 stocks — the bottom half of the AI-ranked universe. Areas of concern include earnings quality (2.2) and institutional flow (18.4), which score below median versus the broader universe. Based on the latest XBRL financial filings (Q1 2026), ULTRALIFE CORP reports quarterly revenue of $47.4M, net income of $-451.0K, an operating margin of -0.4%. Top institutional holders of ULBI by reported 13-F value include Visionary Wealth Advisors, DIMENSIONAL FUND ADVISORS, VANGUARD CAPITAL MANAGEMENT, based on the most recent SEC filings. ULBI trades on the Nasdaq exchange and files with the SEC under CIK 875657. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate ULBI daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for ULTRALIFE CORP directly from SEC EDGAR. ULTRALIFE CORP's 13F Pro composite quality score has ranged between 25 and 60 since 2021, currently 40.8 — a declining long-term trajectory across 30 quarterly and live scoring snapshots.

Fun facts about ULTRALIFE CORP

Quirks, history, and lore behind ULBI — the kind of stuff that makes a stock memorable.

  • 1
    The Basics
    U.S. technology company · small-cap · listed on Nasdaq · headquartered in upstate New York.
  • 2
    The Numbers
    Annual revenue in the range of roughly $100 million, with a significant share of sales going to government and defense customers.
  • 3
    The History
    Tracing its roots back to the 1970s, the company has spent decades supplying specialized power solutions to some of the world's most demanding end-users.
  • 4
    The Secret
    Beyond batteries, it also operates a communications systems segment that sells tactical and two-way radio accessories to military and first-responder markets.
  • 5
    The Lore
    Its non-rechargeable lithium batteries are trusted in some of the harshest environments on earth — think soldiers in the field who really, really can't afford a dead device.
  • 6
    The Giveaway
    This niche New York company's name literally screams long-lasting power, and its ticker — ULBI — is about as subtle as a flashlight in a blackout.
▶ Think you know your stocks? Play the Daily Ticker

Revenue

Q1 2026

$47.4M

Net Income

Q1 2026

$-451.0K

Free Cash Flow

Q1 2026

$1.5M

Operating Margin

Q1 2026

-0.4%

ROIC

Q1 2026

-0.1%

D/E Ratio

Q1 2026

0.37

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro+

Revenue

+16.2% YoY
$191.2MFY 2025
FY22 $131.8MFY23 $158.6MFY24 $164.5MFY25 $191.2M

Net Income

-193.4% YoY
$-5.9MFY 2025
FY22 $-119.0KFY23 $7.2MFY24 $6.3MFY25 $-5.9M

Operating Income

-159.2% YoY
$-5.9MFY 2025
FY22 $129.0KFY23 $9.5MFY24 $10.0MFY25 $-5.9M

EPS (Diluted)

-192.1% YoY
$-35.00FY 2025
FY22 $0.05FY23 $0.44FY24 $38.00FY25 $-35.00

Total Assets

-1.6% YoY
$216.9MFY 2025
FY22 $168.4MFY23 $178.3MFY24 $220.5MFY25 $216.9M

Total Debt

-14.0% YoY
$49.7MFY 2025
FY22 $23.5MFY23 $27.7MFY24 $57.8MFY25 $49.7M

Op. Cash Flow

-33.9% YoY
$11.0MFY 2025
FY22 $-1.3MFY23 $1.9MFY24 $16.6MFY25 $11.0M

AI Insight: ULBI Financial Trends

Ultralife's operating income swung from +$4M in Q2 2024 to -$11M in Q4 2025, eroding equity and signaling a sharp profitability deterioration.

Operating income collapsed from $4M in Q2 2024 to -$11M in Q4 2025, marking a stark reversal over six quarters.

Total debt surged from $8M in Q3 2024 to $58M in Q4 2024, remaining elevated at $48M in Q1 2026.

Equity eroded from $138M in Q2 2025 to $130M in Q1 2026, reflecting cumulative net losses.

Operating cash flow has been near zero for three consecutive quarters (Q3 2025–Q1 2026), ranging from $0M to $2M.

Q4 2025 net loss of -$7M and op loss of -$11M are outlier magnitudes — monitor whether Q1 2026 breakeven holds.

Debt remains ~$50M versus near-zero pre-acquisition levels; debt reduction pace is critical to watch.

Revenue has held $43M–$51M across all eight quarters — stability here is the one constructive data point.

AI Insight: ULBI Ratio Trends

A severe Q4 2025 loss dragged TTM profitability deeply negative, erasing the gains seen through mid-2025.

Operating margin collapsed to -21.9% in Q4 2025 from +4.7% in Q2 2025, pulling TTM OpMargin to -5.1%.

ROIC swung from a peak of 10.8% in Q2 2024 to -23.6% in Q4 2025, signaling capital destruction.

Q1 2026 OpMargin partially recovered to -0.4% from -21.9% in Q4 2025, suggesting the Q4 hit may be partly one-off.

D/E ratio rose sharply from 0.06 in Q3 2024 to 0.43 in Q4 2024 and remains elevated at 0.37 in Q1 2026.

Q4 2025's -21.9% OpMargin looks like a one-off; confirm whether Q1 2026's near-breakeven reflects genuine recovery.

D/E jumped from near-zero (0.06) to ~0.38 range — monitor whether leverage stabilizes or continues climbing.

ROE turned deeply negative at -22.8% in Q4 2025; sustained losses risk further balance sheet erosion.

Get alerted when ULBI's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for ULTRALIFE CORP including:

SEC EDGAR filings (10-K, 10-Q, 8-K)
XBRL financial facts (revenue, EPS, margins)
Insider transactions (Form 4)
Institutional 13F holdings
Quality rankings (32 signals)
AI analyst debates & daily meetings
Historical financial trends
Peer comparison & sector analysis

Put ULBI on your watchlist

Track score changes the day ULTRALIFE CORP files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Is ULBI a good stock to buy?

13F Pro's AI-powered analysis of ULTRALIFE CORP (ULBI) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Technology sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for ULBI are available on the ULBI stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.

Which hedge funds own ULBI?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling ULBI. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of ULTRALIFE CORP's investment landscape.